2010
DOI: 10.1016/j.jss.2010.04.017
|View full text |Cite
|
Sign up to set email alerts
|

Complications After Pancreatectomy for Neuroendocrine Tumors: A National Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
27
0
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(28 citation statements)
references
References 20 publications
0
27
0
1
Order By: Relevance
“…They differ according to the tumor site: lesions of the pancreatic head are treated with a pancreaticoduodenectomy (PD) while lesions of the body and tail with a left pancreatectomy (LP) with or without spleen preservation. Typical pancreatic resections are associated with a high incidence of perioperative complications [95] as well as exocrine and endocrine insufficiency. Atypical resections have been proposed in the management of NF pancreatic NETs, especially when well demarcated and small in size.…”
Section: Type Of Surgerymentioning
confidence: 99%
“…They differ according to the tumor site: lesions of the pancreatic head are treated with a pancreaticoduodenectomy (PD) while lesions of the body and tail with a left pancreatectomy (LP) with or without spleen preservation. Typical pancreatic resections are associated with a high incidence of perioperative complications [95] as well as exocrine and endocrine insufficiency. Atypical resections have been proposed in the management of NF pancreatic NETs, especially when well demarcated and small in size.…”
Section: Type Of Surgerymentioning
confidence: 99%
“…Some authors suggest that for NF-PNETs measuring 2 cm, a nonoperative management can be considered, and the risks and benefits of surgical resection should be carefully weighed in and an overall complication rate of 29.6% after pancreatectomy for PNETs. 20 The majority of complications involved postoperative infections (11.1%), digestive system complications (8.8%), or pulmonary compromise (7.3%). In-hospital mortality EUS-FNA ¼ endoscopic ultrasound-guided fine-needle aspiration; NET ¼ neuroendocrine tumor.…”
Section: Discussionmentioning
confidence: 99%
“…The conservative 'wait and see' management and the parenchyma-sparing techniques, when indicated, can both reduce the risk of pancreas failure and the incidence of tumor recurrence/ malignant progression [7].…”
Section: Introductionmentioning
confidence: 99%